搜尋結果
2021年3月9日 · It is a CD19-directed genetically modified autologous T-cell immunotherapy indicated for use in paediatric and young adult patients ≤25 years of age with B-cell ALL that is refractory, in relapse post-transplantation or in second or later relapse, as well as in adult patients with relapsed/refractory DLBCL after ≥2 lines of systemic therapy.
Search Drug Information, Images & Medical News. The use of bisoprolol does not appear to yield reductions in the number of self-reported chronic obstructive pulmonary disease (COPD) exacerbations requiring treatment with oral corticosteroids, antibiotics, or both, as shown in the placebo-controlled Bisoprolol in COPD Study (BICS).
Method of administration: Up to 5 mL IM; up to 10 mL IV; or 10-50 mL IV infusion over approx 15-60 min. Cerebral metabolic disturbances (dementia) 5-30 mL/day. Post apoplectic defunctionalization symptoms & cranio-cerebral traumata 10-50 mL/day. Childn 1-2 mL/day. Click to view Cerebrolysin detailed prescribing information.
Dosage/Direction for Use. Adult & ped weighing ≥40 kg Single dose of 200 mg IV on day 1 followed by once daily doses of 100 mg IV from day 2. Ped weighing 3.5-<40 kg Single dose 5 mg/kg IV on day 1, followed by 2.5 mg/kg IV from day 2. Prescribing to this patient population should only be considered if therapeutic benefits outweigh the risks.
Oral. Pruritus. Adult: For the management of cases associated with allergic conditions (e.g. chronic urticaria, atopic and contact dermatitis), and in histamine-mediated pruritus: Initially, 25 mg at night, may be increased to 25 mg 3 or 4 times daily if necessary. Max: 100 mg daily.
Flupentixol: Increased risk of neurotoxicity with lithium. Enhanced QTc prolonging effect with QT prolonging agents (e.g. quinidine, sotalol, thioridazine, erythromycin, terfenadine, moxifloxacin). Melitracen: May potentiate the CV effect of epinephrine, norepinephrine, ephedrine, isoprenaline, phenylephrine, and phenylpropanolamine (contained ...
MERCK SHARP & DOHME (ASIA) LTD. Merck Sharp & Dohme (Asia) Ltd (MSD), which is known as Merck & Co. Inc. in the USA, is a global research-driven pharmaceutical company that discovers, develops, manufactures & markets a broad range of valuable breakthrough medicines to improve human health.
